## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt
The relationship between pityriasis rubra pilaris and inflammatory arthritis: Case report and response of the arthritis to anti–tumor necrosis factor immunotherapy
✍ Scribed by Philip G. Conaghan; Sabine Sommer; Dennis McGonagle; Douglas Veale; Herman Waldmann; Geoffrey Hale; Mark Goodfield; Paul Emery; John Isaacs
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 182 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Dynamic contrast‐enhanced MRI (DCE‐MRI) of the hand and wrist was performed in 11 patients with rheumatoid arthritis twice before and once 2 weeks after treatment with anti–tumor necrosis factor (TNF)‐α therapy. A rapid, __T__~1~‐weighted 3D spoiled gradient echo (SPGR) sequence was use
## Objective Several rheumatoid arthritis (RA) susceptibility variants map close to genes involved in the tumor necrosis factor (TNF) signaling pathway, prompting the investigation of RA susceptibility variants in studies of predictors of response to TNF blockade. Based on a previously reported ass